VALLEY FORGE, Pa.--(BUSINESS WIRE)--Oct. 2,
2006--AmerisourceBergen Corporation (NYSE:ABC) today announced that it
plans to release its results for the Fourth Quarter and Fiscal Year
2006 on Thursday, November 2, 2006 prior to the opening of trading on
the New York Stock Exchange. The Company will host a conference call
to discuss the results at 11:00 a.m. Eastern Standard Time on November
2, 2006.
Participating in the conference call will be:
R. David Yost, Chief Executive Officer
Kurt J. Hilzinger, President & Chief Operating Officer
Michael D. DiCandilo, Executive Vice President & Chief
Financial Officer
The dial-in number for the live call will be (612) 234-9960. No
access code is required.
In order to ensure the widest distribution possible, the Company
will be broadcasting the conference call over the Internet. The call
will be accessible through the Investors page of AmerisourceBergen's
web site, www.amerisourcebergen.com. Users are encouraged to log on to
the webcast approximately 15 minutes in advance of the scheduled start
time of the call.
Following the live call, replays will be made available on the
Internet and via telephone. A replay of the webcast will be posted on
www.amerisourcebergen.com approximately two hours after the completion
of the call and will remain available for thirty days. To access the
telephone replay from within the US, dial 800-475-6701. From outside
the US, dial 320-365-3844. The access code is 843841. The telephone
replay will be available from 2:30 p.m. EST on November 2, 2006 to
11:59 p.m. on November 9, 2006.
About AmerisourceBergen
AmerisourceBergen (NYSE:ABC) is one of the world's largest
pharmaceutical services companies serving the United States and
Canada. Servicing both pharmaceutical manufacturers and healthcare
providers in the pharmaceutical supply channel, the Company provides
drug distribution and related services designed to reduce costs and
improve patient outcomes. AmerisourceBergen's service solutions range
from pharmacy automation and pharmaceutical packaging to pharmacy
services for skilled nursing and assisted living facilities,
reimbursement and pharmaceutical consulting services, and physician
education. With nearly $60 billion in annualized revenues,
AmerisourceBergen is headquartered in Valley Forge, PA, and employs
more than 13,000 people. AmerisourceBergen is ranked #27 on the
Fortune 500 list. For more information, go to
www.amerisourcebergen.com.
Forward-Looking Statements
This news release may contain certain "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. These statements
are based on management's current expectations and are subject to
uncertainty and changes in circumstances. Actual results may vary
materially from the expectations contained in the forward-looking
statements. The forward-looking statements herein include statements
addressing management's views with respect to future financial and
operating results and the benefits, efficiencies and savings to be
derived from the Company's integration plan to consolidate its
distribution network. The following factors, among others, could cause
actual results to differ materially from those described in any
forward-looking statements: competitive pressures; the loss of one or
more key customer or supplier relationships; customer defaults or
insolvencies; changes in customer mix; supplier defaults or
insolvencies; changes in pharmaceutical manufacturers' pricing and
distribution policies or practices; adverse resolution of any contract
or other disputes with customers (including departments and agencies
of the U.S. Government) or suppliers; regulatory changes; changes in
U.S. government policies (including reimbursement changes arising from
the Medicare Modernization Act); declines in the amounts of market
share rebates offered by pharmaceutical manufacturers to the
PharMerica long-term care business, declines in the amounts of rebates
that the PharMerica Long-Term Care business can retain, and/or the
inability of the business to offset the rebate reductions that have
already occurred or any rebate reductions that may occur in the
future; fluctuations in market interest rates; operational or control
issues arising from the Company's outsourcing of information
technology activities; the Pharmaceutical Distribution segment's
ability to continue to successfully transition its business model to
fee-for-service; success of integration, restructuring or systems
initiatives; fluctuations in the U.S. dollar - Canadian dollar
exchange rate and other foreign exchange rates; economic, business,
competitive and/or regulatory developments in Canada, the United
Kingdom and elsewhere outside of the United States; acquisition of
businesses that do not perform as we expect or that are difficult for
us to integrate or control; and other economic, business, competitive,
legal, regulatory and/or operational factors affecting the business of
the Company generally. Certain additional factors that management
believes could cause actual outcomes and results to differ materially
from those described in forward-looking statements are set forth (i)
in Item 1 (Business) under the heading "Certain Risk Factors" in the
Company's Annual Report on Form 10-K for the fiscal year ended
September 30, 2005 and elsewhere in that report and (ii) in other
reports filed by the Company pursuant to the Securities Exchange Act
of 1934, including the Company's Quarterly Report on Form 10-Q for the
fiscal quarter ended June 30, 2006.
CONTACT: AmerisourceBergen Corporation
Michael N. Kilpatric, 610-727-7118
mkilpatric@amerisourcebergen.com
SOURCE: AmerisourceBergen Corporation